and Disqualification Recommendations for Competitive Athletes With
Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing
Substances: A Scientific Statement From the American Heart Association and
American College of Cardiology

N.A. Mark Estes III, Richard J. Kovacs,
Aaron L. Baggish, Robert J. Myerburg, and on behalf of the American Heart
Association Electrocardiography and Arrhythmias Committee of the Council on
Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on
Cardiovascular and Stroke Nursing, Council on Functional Genomics and
Translational Biology, and the American College of Cardiology
Circulation. 2015; published online
before print November 2 2015, doi:10.1161/CIR.0000000000000247
The American Heart Association and
American College of Cardiology have released a series of scientific statements
regarding eligibility and disqualification recommendation for competitive
athletes with cardiovascular abnormalities. This is the 12th document of 15
scientific statements. This document discusses the athletic participation and drugs
and performance-enhancing substances. The document includes 5 recommendations at
the end of the document.